Fixed-Dose Combination Therapy in HypertensionPros

被引：6
|
作者：
Stefano Taddei
机构：
[1] University of Pisa,Department of Internal Medicine
来源：
High Blood Pressure & Cardiovascular Prevention | 2012年 / 19卷 / 2期
关键词：
hypertension; antihypertensive therapy; fixed combination therapy;
D O I：
10.1007/BF03262454
中图分类号：
学科分类号：
摘要：
Effective treatment of high blood pressure represents a key strategy for reducing the burden of hypertension-related cardiovascular diseases, mostly myocardial infarction and stroke. Despite these well established concepts, however, hypertension remains poorly controlled, worldwide. In addition, treated hypertensive patients often remain at higher risk compared with the normotensive population, even when a satisfactory blood pressure control is achieved, due to the high or very high added cardiovascular risk profile observed in these patients.
引用
收藏
页码：55 / 57
页数：2
相关论文
共 50 条
  • [21] Fixed-dose combination antituberculosis therapy: is the INH dose adapted for the Tunisianpopulation?
    Ben Tkhayat, Achraf
    Ben Saad, Soumaya
    Daghfous, Hafaoua
    Tritar, Fatma
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [22] Newer approaches to antihypertensive therapy - Use of fixed-dose combination therapy
    Epstein, M
    Bakris, G
    ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (17) : 1969 - 1978
  • [23] Fixed-Dose Combination Therapy (Polypill) for the Prevention of Cardiovascular Disease
    Huffman, Mark D.
    de Cates, Angharad N.
    Ebrahim, Shah
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (19): : 2030 - 2031
  • [24] Fixed-dose combination therapy in the United States, Britain and Israel
    Cohen, E
    Goldschmid, A
    Garty, M
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (08): : 572 - 574
  • [25] MEASURING THE IMPACT OF FIXED-DOSE COMBINATION THERAPY - METHODOLOGICAL CONSIDERATIONS
    CHATELLIER, G
    JOURNAL OF HUMAN HYPERTENSION, 1995, 9 : S27 - S33
  • [26] SPILLOVER ADHERENCE EFFECTS OF FIXED-DOSE COMBINATION HIV THERAPY
    Kauf, T. L.
    Davis, K. L.
    Earnshaw, S. R.
    Davis, E. A.
    Watson, M. E.
    VALUE IN HEALTH, 2009, 12 (07) : A430 - A430
  • [27] Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases
    Bahiru, Ehete
    de Cates, Angharad N.
    Farr, Matthew R. B.
    Jarvis, Morag C.
    Palla, Mohan
    Rees, Karen
    Ebrahim, Shah
    Huffman, Mark D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03):
  • [28] Spillover adherence effects of fixed-dose combination HIV therapy
    Kauf, Teresa L.
    Davis, Keith L.
    Earnshaw, Stephanie R.
    Davis, E. Anne
    PATIENT PREFERENCE AND ADHERENCE, 2012, 6 : 155 - 163
  • [29] Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension
    Sander, Gary E.
    Fernandez, Camilo
    Giles, Thomas D.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (05) : 563 - 572
  • [30] FIXED-DOSE COMBINATION THERAPY FOR HYPERTENSION - METHODS OF CLINICAL DEVELOPMENT
    MENARD, J
    JOURNAL OF HUMAN HYPERTENSION, 1995, 9 : S11 - S17
12345